Clinical Trial Update: Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing Tripterygium wilfordii Hook F to sulfasalazine for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Sulfasalazine (Sulfasalazine)
• Tripterygium wilfordii Hook F (Tripterygium wilfordii Hook F)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED